Class IIOngoingD-0650-2024
Drug recall · September 11, 2024
Semaglutide recall
Why: Lack of Assurance of Sterility
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Semaglutide, 2 mL (2.5mg/mL), Compounded RX Product, Multidose SC inj, glass vial, ProRx, 267-565-7008, NDC 84139-225-01
- Lots / codes
Lot #: ProRx031924, BUD 09/18/2024 ProRx032624, BUD 09/25/2024 ProRx041324, BUD 10/12/2024
- Quantity
- 2,490 vials
- Company
- ProRx LLC, Exton, PA
- Distribution
- Nationwide in the USA
- Initiated
- August 22, 2024 · Voluntary: Firm initiated
- Classified
- September 5, 2024
- Reported
- September 11, 2024
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Class IIOngoingSep 11, 2024Tirzepatide 2 mLProRx LLC · D-0651-2024Class IIOngoingSep 11, 2024SEMAGLUTIDE 5mg/2mLProRx LLC · D-0652-2024Class IIOngoingSep 11, 2024SEMAGLUTIDE 10mg/4mLProRx LLC · D-0653-2024Class IIOngoingSep 11, 2024Semaglutide / Cyanocobalamin Injection: 2.5/0.5 mg/mLProRx LLC · D-0654-2024Class IIOngoingSep 11, 2024TIRZEPATIDE 20 mg/2mLProRx LLC · D-0655-2024Class IIOngoingSep 11, 2024TIRZEPATIDE 60 mg/3mLProRx LLC · D-0656-2024
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.